Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





Income Statement
Balance Sheet
Cash Flow Statement
Segments

Common Size IS
Op Efficiency
Credit Analysis

ReShape Lifesciences Inc. (OBLN)

Income Statement

Standardized | As Reported Annual | Quarterly | TTM
  Older >>
In millions, except per share itemsJun-30-23Mar-31-23Sep-30-22Jun-30-22Mar-31-22Dec-31-21Sep-30-21Jun-30-21
   10-Q10-Q10-Q10-Q10-Q10-K10-Q10-Q
Revenue  2.32.32.82.92.43.13.73.5
            Revenue growth  -22.1%-6.3%-24.5%-18.1%-24.2%-2.0%2.9%107.3%
Cost of revenue  1.11.10.71.01.21.41.61.4
    Gross profit  1.21.22.11.91.21.82.12.2
            Gross margin  53.0%53.5%75.1%65.1%49.9%56.5%57.6%61.0%
   
Operating expenses:          
Sales and marketing  4.66.46.510.08.68.315.55.8
General and administrative  2.44.23.95.43.95.312.14.3
Research and development  0.60.50.60.70.70.31.60.1
(Gain) loss on disposal of assets, net  0.0  0.4    
    Total operating expenses  10.46.914.011.19.337.317.15.9
    Operating loss  -4.0-5.6-11.9-9.2-8.1-35.6-15.0-3.7
            Operating margin  -176.4%-246.2%-426.2%-319.6%-332.5%-1131.7%-404.1%-104.9%
   
Other expense (income), net:          
Interest income, net  0.00.00.00.00.00.00.00.2
Gain on changes in fair value of liability warrants  -0.5-3.0      
(Gain) loss on foreign currency exchange, net   0.00.30.20.00.0-0.1-0.1
Other  0.00.0 0.00.0   
    Loss before income tax provision  -3.5-2.6-12.2-9.4-8.1-35.6-17.7-3.9
Income tax expense  0.00.0-0.40.00.0-0.10.00.0
    Net loss  -3.5-2.7-11.8-9.4-8.1-35.5-17.7-3.9
   
Net loss per share - basic and diluted:          
Net loss per share - basic (in dollars per share)  ($1.08)($1.56)($0.52)($24.45)($21.87)($2.49)($1.04)($0.86)
Net loss per share - diluted (in dollars per share)  ($1.08)($1.56)($0.52)($24.45)($21.87)($2.49)($1.04)($0.86)
   
Shares used to compute basic net loss per share (in shares)  3.21.722.60.40.412.417.14.6
Shares used to compute diluted net loss per share (in shares)  3.21.722.60.40.412.417.14.6

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy